Amgen thyroid drug succeeds in late-stage trial
August 18, 2014 at 17:55 PM EDT
Aug 18 (Reuters) - Drugmaker Amgen Inc said its experimental drug to reduce thyroid levels in patients with chronic kidney disease met the main goal in a late-stage trial.
